Cross-reactive broadly neutralizing antibodies: timing is everything

Por Euler, Zelda, Schuitemaker, Hanneke
Publicado em 2012

Exploring the Potential of Monoclonal Antibody Therapeutics for HIV-1 Eradication

Por Euler, Zelda, Alter, Galit
Publicado no AIDS Res Hum Retroviruses (2015)

Blimp-1, an Intrinsic Factor that Represses HIV-1 Proviral Transcription in Memory CD4(+) T Cells

Por Michaels, Katarzyna Kaczmarek, Natarajan, Malini, Euler, Zelda, Alter, Galit, Viglianti, Gregory, Henderson, Andrew J.
Publicado no J Immunol (2015)

HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients

Por van den Kerkhof, Tom, van Gils, Marit, Euler, Zelda, Verwer, Naomi, Sanders, Rogier, Schuitemaker, Hanneke
Publicado em 2011

Genome-Wide Association Study on the Development of Cross-Reactive Neutralizing Antibodies in HIV-1 Infected Individuals

Por Euler, Zelda, van Gils, Marit J., Boeser-Nunnink, Brigitte D., Schuitemaker, Hanneke, van Manen, Daniëlle
Publicado em 2013

Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic

Por Euler, Zelda, Bunnik, Evelien M., Burger, Judith A., Boeser-Nunnink, Brigitte D. M., Grijsen, Marlous L., Prins, Jan M., Schuitemaker, Hanneke
Publicado em 2011

Longitudinal Analysis of Early HIV-1-Specific Neutralizing Activity in an Elite Neutralizer and in Five Patients Who Developed Cross-Reactive Neutralizing Activity

Por Euler, Zelda, van den Kerkhof, Tom L. G. M., van Gils, Marit J., Burger, Judith A., Edo-Matas, Diana, Phung, Pham, Wrin, Terri, Schuitemaker, Hanneke
Publicado em 2012

HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity

Por van den Kerkhof, Tom L G M, Feenstra, K Anton, Euler, Zelda, van Gils, Marit J, Rijsdijk, Linda W E, Boeser-Nunnink, Brigitte D, Heringa, Jaap, Schuitemaker, Hanneke, Sanders, Rogier W
Publicado em 2013

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

Por Mouquet, Hugo, Scharf, Louise, Euler, Zelda, Liu, Yan, Eden, Caroline, Scheid, Johannes F., Halper-Stromberg, Ariel, Gnanapragasam, Priyanthi N. P., Spencer, Daniel I. R., Seaman, Michael S., Schuitemaker, Hanneke, Feizi, Ten, Nussenzweig, Michel C., Bjorkman, Pamela J.
Publicado em 2012

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies

Por McCoy, Laura E., Falkowska, Emilia, Doores, Katie J., Le, Khoa, Sok, Devin, van Gils, Marit J., Euler, Zelda, Burger, Judith A., Seaman, Michael S., Sanders, Rogier W., Schuitemaker, Hanneke, Poignard, Pascal, Wrin, Terri, Burton, Dennis R.
Publicado no PLoS Pathog (2015)

Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011

Por Ruffin, Nicolas, Borggren, Marie, Euler, Zelda, Fiorino, Fabio, Grupping, Katrijn, Hallengärd, David, Javed, Aneele, Mendonca, Kevin, Pollard, Charlotte, Reinhart, David, Saba, Elisa, Sheik-Khalil, Enas, Sköld, Annette, Ziglio, Serena, Scarlatti, Gabriella, Gotch, Frances, Wahren, Britta, Shattock, Robin J
Publicado em 2012

The Development of CD4 Binding Site Antibodies during HIV-1 Infection

Por Lynch, Rebecca M., Tran, Lillian, Louder, Mark K., Schmidt, Stephen D., Cohen, Myron, DerSimonian, Rebecca, Euler, Zelda, Gray, Elin S., Abdool Karim, Salim, Kirchherr, Jennifer, Montefiori, David C., Sibeko, Sengeziwe, Soderberg, Kelly, Tomaras, Georgia, Yang, Zhi-Yong, Nabel, Gary J., Schuitemaker, Hanneke, Morris, Lynn, Haynes, Barton F., Mascola, John R.
Publicado em 2012